Clinical Research Core

We have designed the Clinical Research Core (CRC) in accordance with our extensive experience with clinical research, including clinical research on the prevention and diagnosis of multiple infectious diseases. The clinical research core does not provide care or research on patients with infectious diseases. The fundamental goal of the CRC in the NEIDL is to provide a dedicated location and trained staff to the network of researchers in the NEIDL, the Regional Centers of Excellence in Emerging Infectious Diseases, the Regional Biocontainment Laboratories, the Galveston National Biocontainment Laboratory, as well as private entities who are doing sponsored research to fulfill the NIAID’s strategic plan for the development of new treatments and vaccines against emerging infectious diseases.

Functions and Services

The CRC facility will provide investigators with the ability to conduct IRB approved studies on normal human volunteers. We anticipate that the CRC will perform studies that include phase 1 vaccine studies, lot consistency studies, examine novel immunogen delivery systems by various routes, examine candidate vaccine stability, pharmacokinetics of novel therapeutics, delivery of therapeutics through alternative routes (e.g., respiratory, oral, mucosal, transdermal), and phase 1 safety trials of biologicals (e.g., therapeutic antibodies).